Connection

Bobby Thomas to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine

This is a "connection" page, showing publications Bobby Thomas has written about 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
  1. Resistance to MPTP-neurotoxicity in a-synuclein knockout mice is complemented by human a-synuclein and associated with increased ?-synuclein and Akt activation. PLoS One. 2011 Jan 31; 6(1):e16706.
    View in: PubMed
    Score: 0.370
  2. Bach1 derepression is neuroprotective in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A. 2021 11 09; 118(45).
    View in: PubMed
    Score: 0.195
  3. Distinct Nrf2 Signaling Mechanisms of Fumaric Acid Esters and Their Role in Neuroprotection against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine-Induced Experimental Parkinson's-Like Disease. J Neurosci. 2016 06 08; 36(23):6332-51.
    View in: PubMed
    Score: 0.134
  4. Mitochondrial permeability transition pore component cyclophilin D distinguishes nigrostriatal dopaminergic death paradigms in the MPTP mouse model of Parkinson's disease. Antioxid Redox Signal. 2012 May 01; 16(9):855-68.
    View in: PubMed
    Score: 0.095
  5. MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity. Neurobiol Dis. 2007 May; 26(2):312-22.
    View in: PubMed
    Score: 0.070
  6. Unexpected lack of hypersensitivity in LRRK2 knock-out mice to MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine). J Neurosci. 2009 Dec 16; 29(50):15846-50.
    View in: PubMed
    Score: 0.021
  7. Nitric oxide: an antioxidant and neuroprotector. Ann N Y Acad Sci. 2002 May; 962:389-401.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.